AstraZeneca PLC AZN.L Stock
AstraZeneca PLC Price Chart
AstraZeneca PLC AZN.L Financial and Trading Overview
AstraZeneca PLC stock price | 11020 GBP |
Previous Close | 11686 GBP |
Open | 11720 GBP |
Bid | 11856 GBP x 0 |
Ask | 11858 GBP x 0 |
Day's Range | 11718 - 11878 GBP |
52 Week Range | 9499.21 - 12828.45 GBP |
Volume | 322.9K GBP |
Avg. Volume | 1.71M GBP |
Market Cap | 183.54B GBP |
Beta (5Y Monthly) | 0.194636 |
PE Ratio (TTM) | 48.73251 |
EPS (TTM) | 3.03 GBP |
Forward Dividend & Yield | 2.39 (2.08%) |
Ex-Dividend Date | February 23, 2023 |
1y Target Est | 124.25 GBP |
AZN.L Valuation Measures
Enterprise Value | 207.05B GBP |
Trailing P/E | 48.73251 |
Forward P/E | 17.414705 |
PEG Ratio (5 yr expected) | 2.44 |
Price/Sales (ttm) | 4.186487 |
Price/Book (mrq) | 512.5298 |
Enterprise Value/Revenue | 4.723 |
Enterprise Value/EBITDA | 13.909 |
Trading Information
AstraZeneca PLC Stock Price History
Beta (5Y Monthly) | 0.194636 |
52-Week Change | 15.98% |
S&P500 52-Week Change | 20.43% |
52 Week High | 12828.45 GBP |
52 Week Low | 9499.21 GBP |
50-Day Moving Average | 11820.6 GBP |
200-Day Moving Average | 11045.67 GBP |
AZN.L Share Statistics
Avg. Volume (3 month) | 1.71M GBP |
Avg. Daily Volume (10-Days) | 1.65M GBP |
Shares Outstanding | 1.55B |
Float | 1.54B |
Short Ratio | N/A |
% Held by Insiders | 0.23% |
% Held by Institutions | 50.59% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 2.9 |
Trailing Annual Dividend Yield | 0.024% |
5 Year Average Dividend Yield | 271.00% |
Payout Ratio | 0.945 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 10.73% |
Operating Margin (ttm) | 23.09% |
Gross Margin | 84.30% |
EBITDA Margin | 33.95% |
Management Effectiveness
Return on Assets (ttm) | 6.42% |
Return on Equity (ttm) | 13.05% |
Income Statement
Revenue (ttm) | 43.84B GBP |
Revenue Per Share (ttm) | 28.32 GBP |
Quarterly Revenue Growth (yoy) | -4.50% |
Gross Profit (ttm) | 35.73B GBP |
EBITDA | 14.89B GBP |
Net Income Avi to Common (ttm) | 4.7B GBP |
Diluted EPS (ttm) | 2.43 |
Quarterly Earnings Growth (yoy) | 367.09% |
Balance Sheet
Total Cash (mrq) | 6.46B GBP |
Total Cash Per Share (mrq) | 4.17 GBP |
Total Debt (mrq) | 32.47B GBP |
Total Debt/Equity (mrq) | 90.68 GBP |
Current Ratio (mrq) | 0.896 |
Book Value Per Share (mrq) | 23.105 |
Cash Flow Statement
Operating Cash Flow (ttm) | 9.71B GBP |
Levered Free Cash Flow (ttm) | 9.69B GBP |
Profile of AstraZeneca PLC
Country | United Kingdom |
State | N/A |
City | Cambridge |
Address | 1 Francis Crick Avenue |
ZIP | CB2 0AA |
Phone | 44 20 3749 5000 |
Website | https://www.astrazeneca.com |
Industry | Drug Manufacturers-General |
Sector(s) | Healthcare |
Full Time Employees | 83500 |
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc, as well as research collaboration with Sernova Corp. to evaluate novel potential therapeutic cell applications. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Q&A For AstraZeneca PLC Stock
What is a current AZN.L stock price?
AstraZeneca PLC AZN.L stock price today per share is 11020 GBP.
How to purchase AstraZeneca PLC stock?
You can buy AZN.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AstraZeneca PLC?
The stock symbol or ticker of AstraZeneca PLC is AZN.L.
Which industry does the AstraZeneca PLC company belong to?
The AstraZeneca PLC industry is Drug Manufacturers-General.
How many shares does AstraZeneca PLC have in circulation?
The max supply of AstraZeneca PLC shares is 15.56M.
What is AstraZeneca PLC Price to Earnings Ratio (PE Ratio)?
AstraZeneca PLC PE Ratio is 36.51485000 now.
What was AstraZeneca PLC earnings per share over the trailing 12 months (TTM)?
AstraZeneca PLC EPS is 3.03 GBP over the trailing 12 months.
Which sector does the AstraZeneca PLC company belong to?
The AstraZeneca PLC sector is Healthcare.
AstraZeneca PLC AZN.L included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
ISE Mini FTSE 100 Index UKX | — — |
0
|
— — | — — | — — | — - | — — |
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
Nasdaq CRD Global Sustainabilit NQCRD | 1735.62 USD — |
0
|
— — | 1715.94 USD — | 1757.95 USD — | — - | — — |
FTSE 350 FTLC | 4398.53 GBP 5625.44 USD |
+0.73
|
— — | 4366.53 GBP 5584.51 USD | 4428.44 GBP 5663.69 USD | — - | — — |
NASDAQ AlphaDEX United Kingdom NQDXGBN | 1207.51 USD — |
-0.23
|
— — | 1207.13 USD — | 1207.9 USD — | — - | — — |
Nasdaq Developed Select Leaders NQDMSLC | 1260.81 USD — |
0
|
— — | 1243.71 USD — | 1264.94 USD — | — - | — — |
FTSE 100 FTSE | 7995.58 GBP 10225.83 USD |
+0.91
|
— — | 7923.8 GBP 10134.03 USD | 8044.98 GBP 10289.01 USD | — - | — — |
UK FTSE All Share FTAS | 4353.66 GBP 5568.05 USD |
+0.72
|
— — | 4322.37 GBP 5528.03 USD | 4382.9 GBP 5605.45 USD | — - | — — |
- {{ link.label }} {{link}}